Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Old and new vaccine approaches.

Ruth Arnon1, Tamar Ben-Yedidia

  • 1Department of Immunology, The Weizmann Institute, PO Box 26, 76100 Rehovot, Israel. ruth.arnon@weizman.ac.il

International Immunopharmacology
|July 16, 2003
PubMed
Summary

New vaccine technologies like recombinant, DNA, and peptide vaccines overcome traditional limitations. These advanced approaches offer potential for treating chronic infections and non-infectious diseases such as cancer.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Glatiramer Acetate for the Treatment of Multiple Sclerosis: From First-Generation Therapy to Elucidation of Immunomodulation and Repair.

Pharmacological reviews·2024
Same author

Repurposing of glatiramer acetate to treat cardiac ischemia in rodent models.

Nature cardiovascular research·2024
Same author

Nanobodies to multiple spike variants and inhalation of nanobody-containing aerosols neutralize SARS-CoV-2 in cell culture and hamsters.

Antiviral research·2023
Same author

Amyloid Precursor Protein and Tau Peptides Linked Together Ameliorate Loss of Cognition in an Alzheimer's Disease Animal Model.

International journal of molecular sciences·2023
Same author

Prof. Michael Sela (1924-2022).

European journal of immunology·2022
Same author

Role of Helical Structure in MBP Immunodominant Peptides for Efficient IgM Antibody Recognition in Multiple Sclerosis.

Frontiers in chemistry·2022

Area of Science:

  • Vaccinology
  • Immunology
  • Biotechnology

Background:

  • Conventional vaccines face limitations hindering future development.
  • Novel vaccine strategies are crucial for addressing unmet medical needs.

Purpose of the Study:

  • To review emerging vaccine technologies beyond conventional methods.
  • To highlight the potential of new vaccine platforms for various diseases.

Main Methods:

  • Development of recombinant vaccines using protective antigens or live vectors.
  • Exploration of naked DNA vaccines encoding protective antigens.
  • Design of peptide vaccines with defined epitopes.
  • Emphasis on carrier/adjuvant technology for effective antigen presentation and delivery.

Main Results:

  • Recombinant vaccines involve expressing protective antigens or using live vectors.
  • Naked DNA vaccines utilize genes for protective antigens.
  • Peptide vaccines incorporate specific B and T cell epitopes.
  • Efficacy relies on advanced presentation and delivery systems, including adjuvants.

Conclusions:

  • Emerging vaccine technologies offer promising alternatives to conventional vaccines.
  • These novel approaches have potential applications in infectious and non-infectious diseases, including cancer and autoimmune disorders.
  • Further research into delivery and adjuvant technologies is essential for optimizing vaccine efficacy.

Related Experiment Videos